Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 8/20 | 0.53 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21805747 | 1.00 | P2RY10 (0.53) | P2RY10GPR34DGKAFOLH1NAALAD2 | |
| SCHEMBL21804883 | 0.90 | FOLH1 (0.51) | P2RY10GPR34DGKAFOLH1NAALAD2 | |
| SCHEMBL8359802 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| Cetyl Palmitate SCHEMBL7134252 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| Cetyl Palmitate SCHEMBL9115642 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| SCHEMBL21465347 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| SCHEMBL8354363 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| SCHEMBL8820849 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| SCHEMBL8356466 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA | |
| SCHEMBL22973781 | 0.83 | DGKA (0.62) | P2RY10GPR34DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323985-A1 | SHIELDING AGENTS AND THEIR USE | ENDOCYTE INC (US) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323985-A1 | SHIELDING AGENTS AND THEIR USE | PSMA6, PSMA2, PSMA1 | P2RY10 3823/4885GPR34 3474/4885DGKA 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.